Journal of Substance Abuse Treatment
Volume 36, Issue 3 , Pages 339-344 , April 2009

Are cannabis users who participate in a randomized clinical trial different from other treatment seekers?

  • Amie R. Frewen, B.Psych.

      Affiliations

    • Centre for Emotional Health, Psychology Department, Macquarie University, Epping, Sydney NSW, Australia 2019
    • The Langton Centre, Surry Hills, Sydney NSW, Australia 2010
    • National Drug and Alcohol Research Centre, Randwick, Sydney 2031
    • Corresponding Author InformationCorresponding author. National Cannabis Information and Prevention Centre, NDARC, University of NSW, Building R1, 22-23 King St., Randwick NSW 2031. Tel.: +612 9385 0308; fax: +612 9385 0222.
    • ,
  • Andrew J. Baillie, Ph.D., M.Psychol.

      Affiliations

    • Centre for Emotional Health, Psychology Department, Macquarie University, Epping, Sydney NSW, Australia 2019
    • ,
  • Mark E. Montebello, M.B.B.S., F.R.A.N.Z.C.P., F.A.Ch.A.M.

      Affiliations

    • The Langton Centre, Surry Hills, Sydney NSW, Australia 2010
    • National Drug and Alcohol Research Centre, Randwick, Sydney 2031

Received 19 February 2008 ,Revised 8 July 2008 ,Accepted 17 July 2008.

References 

  1. Andersen R. Revisiting the behavioral model and access to medical care: Does it matter?. Journal of Health and Social Behavior. 1995;36:1–10
  2. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly. 1973;51:95–124
  3. Anthony JC, Warner LA, Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology. 1994;2:224–268
  4. Australian Institute of Health and Welfare . Alcohol and other drug treatment services in Australia 2005–06: Report on the National Minimum Data Set. Drug treatment data briefing. Canberra: Australian Institute of Health & Welfare; 2007;
  5. Australian Institute of Health and Welfare . 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series number 20.Cat. no. PHE 98. Canberra: AIHW; 2008;
  6. Black E. Preliminary findings from the 2007 IDRS. In: Presented at 2007 National Drug Trends Conference Monday 15th October 2007. Sydney, National Drug & Alcohol Research Centre. 2007;
  7. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Threats to applicability of randomized trials: Exclusions and selective participation. Journal of Health Services & Research Policy. 1999;4:112–121
  8. Copeland J, Swift W, Rees VW. Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment. 2001;20:45–52
  9. Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive–behavioural interventions for cannabis use disorder. Journal of Substance Abuse Treatment. 2001;21:55–64
  10. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98:1493–1504
  11. Epstein J. Substance dependence, abuse and treatment: Findings from the 2000 National Household Survey on Drug Abuse. Substance Abuse and Mental Health Services. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2002;Also available at http://www.oas.samhsa.gov/analytic.htm
  12. Goldberg D, Huxley P. Common mental disorders: A bio-social model. London: Routledge; 1992;
  13. Goldberg D, Huxley PJ. Mental illness in the community: The pathway to psychiatric care. London: Tavistock Publications; 1980;
  14. Grant B. Toward an alcohol treatment model: A comparison of treatment and untreated respondents with DSM-IV alcohol use disorders in the general population. Alcoholism: Clinical and Experimental Research. 1996;20:372–378
  15. Huxley PJ. Mental illness in the community: The Goldberg–Huxley model of the pathway to psychiatric care. Nordic Journal of Psychiatry. 1996;50:47–53
  16. Issakidis C, Andrews G. Who treats whom? An application of the Pathways to Care model in Australia. Australian & New Zealand Journal of Psychiatry. 2006;40:74–86
  17. Kessler R, Nelson C, McGonagle K, Edlund M, Frank R, Leaf P. The epidemiology of co-occurring addictive and mental disorders: implication for prevention and service utilization. American Journal of Orthopsychiatry. 1996;66:17–31
  18. Licht R. Limitations in randomized controlled trials evaluating drug effects in mania. European Archives of Psychiatry and Clinical Neuroscience. 2001;251:66–71
  19. Licht R, Gouliaev G, Per F. Generalisability of results from randomised drug trials: A trial on antimanic treatment. British Journal of Psychiatry. 1997;170:264–267
  20. Rapp R, Xu J, Carr C, Lane T, Wang J, Carlson R. Treatment barriers identified by substance abusers assessed at a centralized intake unit. Journal of Substance Abuse Treatment. 2006;30:227–235
  21. Reilly D, Didcott P, Swift W, Hall W. Long-term cannabis users on the New South Wales North Coast, NDARC Monograph No. 30. Sydney: National Drug & Alcohol Research Centre; 1997;
  22. Ross H, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry. 1988;45:1023–1031
  23. Rush B, Urbanoski K. Estimating the demand for treatment for cannabis-related problems in Canada. International Journal of Mental Health and Addiction. 2007;5:181–186
  24. Saunders S, Zygowicz K, D'Angelo B. Person-related and treatment-related barriers to alcohol treatment. Journal of Substance Abuse Treatment. 2006;30:261–270
  25. Stirman S, DeRubeis R, Crits-Christoph P, Rothman A. Can the randomized controlled trial literature generalize to nonrandomized patients?. Journal of Consulting and Clinical Psychology. 2005;73:127–135
  26. Stephens R, Roffman R, Simpson E. Adult marijuana users seeking treatment. Journal of Consulting and Clinical Psychology. 1993;61:1100–1104
  27. Treloar C, Abelson J, Cao W, Brener L, Kippax S, Schultz L, et al. Monograph series no. 53. Barriers and incentives to treatment for illicit drugs users. Canberra: Commonwealth of Australia; 2004;
  28. Tsogia D, Copello A, Orford J. Entering treatment for substance misuse: A review of the literature. Journal of Mental Health. 2001;10:481–499

PII: S0740-5472(08)00122-0

doi: 10.1016/j.jsat.2008.07.004

Journal of Substance Abuse Treatment
Volume 36, Issue 3 , Pages 339-344 , April 2009

Article Tools